Hochhaus A. et al. Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia // N. Engl. J. Med. 2017. Vol. 376, № 10. P. 917–927.
88
O’Brien S.G. et al. Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia // N. Engl. J. Med. 2003. Vol. 348, № 11. P. 994–1004.
